Testosterone Enanthate: Dosage, Cycle Length, and PCT
Dosage, cycle length, E2 control, bloodwork, and PCT timing — the complete testosterone enanthate guide.
Testosterone Enanthate: Dosage, Cycle Length, and PCT
TL;DR
- Testosterone enanthate is a long-ester injectable with a half-life of roughly 4.5–7 days, making one to two injections per week sufficient for stable blood levels.
- The standard beginner dose is 250–500 mg per week, split into two equal injections; returns above 500 mg diminish quickly while side effects scale up.
- A typical first cycle runs 10–12 weeks, followed by a two-week clearance gap before PCT begins.
- Testosterone aromatises to oestradiol — E2 management by bloodwork, not by feel, is the core skill of running this compound.
- PCT starts approximately 14 days after the last injection, once the long ester has cleared, and typically runs four weeks with a SERM.
- Bloodwork before, during, and after the cycle is non-negotiable: total/free testosterone, oestradiol, lipids, liver enzymes, and haematocrit.
What Testosterone Enanthate Is
Testosterone enanthate is testosterone bound to the enanthate ester, a seven-carbon fatty acid chain that slows release from the intramuscular depot. Once injected, enzymes cleave the ester and release free testosterone into circulation over days rather than hours. Pharmacologically, the active molecule is identical to the testosterone your body produces — the anabolic-androgenic ratio of 100:100 is defined by this hormone, and every other anabolic steroid is benchmarked against it.
That reference status is why it remains the foundation of most first cycles: it is the most extensively studied anabolic compound in existence, its effects are predictable, and its side-effect profile is well mapped from decades of European clinical use as a depot preparation for hypogonadism.
Enanthate vs. other esters
The ester determines release kinetics, not potency — 250 mg of testosterone enanthate and 250 mg of testosterone cypionate deliver nearly identical outcomes.
Ester | Half-life | Injections per week | Clearance after last shot |
|---|---|---|---|
Testosterone propionate | ~2–3 days | 3–7 | ~3–5 days |
Testosterone enanthate | ~4.5–7 days | 1–2 | ~10–14 days |
Testosterone cypionate | ~5–8 days | 1–2 | ~10–14 days |
Testosterone undecanoate | ~20+ days | 1 every 2–4 weeks | 4+ weeks |
The practical trade-off: long esters mean fewer injections and smoother levels, but a slower exit if side effects force you to stop. For a first cycle, that stability wins.
Dosage: What the Practice Looks Like
Dosage norms in performance contexts cluster into well-established bands:
Experience level | Weekly dose | Injection schedule |
|---|---|---|
Beginner | 250–500 mg | 2 × per week (e.g. Mon/Thu) |
Intermediate | 500–750 mg | 2 × per week |
Advanced | 750 mg+ | 2 × per week |
Splitting the weekly dose into two equal injections — for example 250 mg on Monday and 250 mg on Thursday — keeps serum levels within a narrow band and flattens the oestradiol peaks that drive most estrogenic side effects.
Two points matter more than the number itself. First, dose-response is not linear: the marginal gain between 300 mg and 500 mg per week is substantial, while the jump from 500 mg to 750 mg adds modest benefit and a disproportionate increase in aromatisation, haematocrit, and blood pressure load. Second, more is only better when your monitoring scales with it — and few beginners are equipped to monitor a 750 mg cycle properly.
Concentrations in practice
Enanthate is typically supplied at 250 mg/ml or 300 mg/ml. At 250 mg/ml, a 500 mg week is two 1 ml injections — simple arithmetic, easy to dose accurately. We stock testosterone enanthate from several EU-verified labs, including Enanthate 250 by Elite Pharm at the standard 250 mg/ml concentration, Testabol Enanthate by British Dragon, and the higher-concentration Enanta-Med 300 by Bioniche Pharma for those who want less injection volume per week. The full range is in the testosterone enanthate category, which with 36 products is the deepest single-compound selection in the shop.
Cycle Length and a Week-by-Week Plan
Long esters need time to saturate. Blood levels do not reach steady state until weeks 3–4, and the noticeable training effects — strength climbing, recovery shortening, pumps that persist — typically arrive between weeks 3 and 6. A cycle shorter than 10 weeks wastes the saturation phase; beyond 12–14 weeks, the suppression burden and lipid/haematocrit drift accumulate without proportionate returns.
Week | Testosterone enanthate | Supporting actions |
|---|---|---|
0 | — | Baseline bloodwork: hormones, lipids, liver, haematocrit, blood pressure |
1–12 | 2 × 250 mg/week | Training and diet dialled in; AI only if bloodwork demands it |
5–6 | — | Mid-cycle bloodwork: total T, E2 sensitive, lipids, haematocrit |
13–14 | None | Ester clearance — levels decline over ~2 weeks |
15–18 | PCT | SERM protocol (see PCT section) |
20+ | — | Post-PCT bloodwork to confirm recovery |
The mid-cycle blood draw is the one most people skip — and the one that matters most, because it is your only chance to correct E2 or a climbing haematocrit while there is still time to act.
Managing Oestradiol: The Core Skill
Testosterone aromatises — a fraction is converted to oestradiol by the aromatase enzyme, proportionally to dose. Some E2 elevation is desirable: oestradiol supports joint health, libido, mood, and lipid balance. The problems start at the extremes. Too high, and you get water retention, rising blood pressure, emotional volatility, and gynecomastia risk. Crashed too low by an overzealous aromatase inhibitor, and you get joint pain, flat mood, lost libido, and worsened lipids — often mistaken for "the compound not working."
The governing rule is: dose the AI to bloodwork, never to symptoms alone, and never prophylactically at fixed doses from day one. A mid-cycle E2 sensitive assay tells you whether you need anastrozole at all, and at what dose. The full decision framework — when to reach for an AI versus a SERM, and how to read E2 in context — is covered in Aromatase Inhibitors vs SERMs: Mastering E2 Control on Cycle.
Gynecomastia deserves specific mention: early signs (nipple sensitivity, itching, palpable tissue) demand immediate attention, because established glandular tissue does not resolve on its own. At 250–500 mg/week with monitored E2, the risk is manageable — ignored, it is not.
Bloodwork: What to Test and When
Running testosterone without bloodwork is driving blindfolded. The minimum panel covers three time points — baseline, mid-cycle (week 5–6), and post-PCT — and should include:
- Total and free testosterone, LH, FSH: confirms the product is real and dosed (total T should be well above reference range mid-cycle) and quantifies recovery after PCT.
- Oestradiol (sensitive assay): the steering wheel for AI decisions.
- Lipid panel (HDL, LDL, triglycerides): testosterone suppresses HDL modestly; expect a dip and track its recovery.
- Liver enzymes (ALT, AST, GGT): injectable testosterone is not hepatotoxic, but a baseline matters if you add orals later.
- Haematocrit and haemoglobin: testosterone stimulates erythropoiesis; haematocrit above ~0.54 warrants dose reduction or phlebotomy.
- Blood pressure: home monitoring twice weekly; estrogenic water retention pushes it up.
Reference ranges and the reasoning behind each marker are laid out in Blood Tests on a Steroid Cycle: 12 Key Markers & Reference Values.
Side Effects and Who Should Not Use It
At 250–500 mg/week with proper monitoring, testosterone enanthate is among the most manageable anabolic compounds — but "manageable" is not "harmless":
- Suppression: your natural production shuts down within weeks. This is guaranteed, not probabilistic — hence PCT.
- Estrogenic effects: water retention, blood pressure elevation, gynecomastia risk (managed via E2 control above).
- Androgenic effects: acne and accelerated hair loss in those genetically predisposed to male-pattern baldness. If baldness runs in your family, assume testosterone will speed the clock.
- Cardiovascular strain: HDL suppression, haematocrit elevation, and potential left-ventricular remodelling with long-term heavy use.
- Fertility: sperm production is suppressed during the cycle; recovery usually follows but can take months.
Do not run a cycle if you are under roughly 25 (endocrine development is still completing), if your baseline bloodwork shows pre-existing lipid, liver, or haematological abnormalities, if you have uncontrolled hypertension, or if you cannot commit to the monitoring and PCT protocol. If any of those apply, the correct decision is to wait or abstain — the compound will still exist next year.
PCT After a Long Ester
Post-cycle therapy exists to restart the hypothalamic-pituitary-gonadal axis after exogenous testosterone is withdrawn. Timing is ester-dependent and often gotten wrong: start too early and the SERMs fight still-suppressive exogenous hormone. Enanthate levels decline over roughly two weeks after the final shot, so PCT begins approximately 14 days after the last injection.
A standard protocol runs four weeks: tamoxifen at 20 mg/day, or enclomiphene at 12.5–25 mg/day, sometimes front-loaded at a higher dose for the first week. The SERMs and supporting compounds for this phase are grouped in the PCT category. Recovery is verified, not assumed: post-PCT bloodwork (LH, FSH, total testosterone) three to four weeks after the protocol ends tells you whether the axis has actually restarted. Skipping PCT entirely risks months of hypogonadal symptoms: lost gains, depressed mood, absent libido, and poor training capacity.
FAQ
Is 250 mg per week enough for a first cycle?
For many beginners, yes — 250 mg/week produces measurable gains with a markedly lower side-effect burden than 500 mg. The case for 500 mg as the standard first dose is stronger results in the same timeframe; the case for 250 mg is an easier introduction to managing E2 and blood pressure. Below 250 mg, the suppression cost outweighs the anabolic return.
How long until testosterone enanthate kicks in?
Serum levels begin rising within days, but steady state takes 3–4 weeks. Most users report clear strength and recovery improvements between weeks 3 and 6. If you feel nothing by week 6 at 500 mg/week, verify with bloodwork — underdosed product is common on the grey market.
Do I need an aromatase inhibitor from day one?
No. Prophylactic AI use from week one risks crashing E2 before it has even risen, trading estrogenic sides for low-oestrogen sides that feel worse and damage lipids more. Start the AI only when mid-cycle bloodwork (or confirmed high-E2 symptoms) justifies it, at the lowest effective dose.
Can I extend the cycle to 16 or 20 weeks?
You can, and some do — but the trade-offs sharpen: longer suppression means slower and less certain recovery, haematocrit and lipids drift further from baseline, and the additional gains over weeks 13–20 are modest compared to weeks 4–12. For a first or second cycle, 10–12 weeks is the rational ceiling.
Is post-injection pain normal?
Mild soreness for 24–72 hours after an injection is common, especially early on. Severe or worsening pain, redness, warmth, or fever is not normal and suggests infection — that requires medical attention, not forum advice. Sterile technique, site rotation, and warming the oil to body temperature eliminate most avoidable PIP.
Conclusion
Testosterone enanthate holds its position as the default first injectable not through marketing but through predictability: known doses, known kinetics, known risks, and a side-effect profile that responds to monitoring. The formula is unglamorous — 250–500 mg per week, 10–12 weeks, two injections per week, three blood draws, E2 managed by numbers rather than guesswork, and a properly timed PCT once the ester clears. The athletes who keep their gains are the ones who make bloodwork part of the cycle rather than an optional extra, who keep doses at the level their monitoring supports, and who accept that recovery is earned in the weeks after the last injection. Respect the compound, and it is remarkably consistent; cut corners, and it will invoice you later.
